These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10487526)

  • 1. Induction of apoptosis by dexrazoxane (ICRF-187) through caspases in the absence of c-jun expression and c-Jun NH2-terminal kinase 1 (JNK1) activation in VM-26-resistant CEM cells.
    Khélifa T; Beck WT
    Biochem Pharmacol; 1999 Oct; 58(8):1247-57. PubMed ID: 10487526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease.
    Khélifa T; Beck WT
    Mol Pharmacol; 1999 Mar; 55(3):548-56. PubMed ID: 10051540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE; Cadena RS; Raimondi SC; Beck WT
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
    Kim R; Beck WT
    Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage signals induction of fas ligand in tumor cells.
    Mo YY; Beck WT
    Mol Pharmacol; 1999 Feb; 55(2):216-22. PubMed ID: 9927611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teniposide-resistant CEM cells, which express mutant DNA topoisomerase II alpha, when treated with non-complex-stabilizing inhibitors of the enzyme, display no cross-resistance and reveal aberrant functions of the mutant enzyme.
    Chen M; Beck WT
    Cancer Res; 1993 Dec; 53(24):5946-53. PubMed ID: 8261408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis.
    Seimiya H; Mashima T; Toho M; Tsuruo T
    J Biol Chem; 1997 Feb; 272(7):4631-6. PubMed ID: 9020192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells.
    Hasinoff BB; Abram ME; Barnabé N; Khélifa T; Allan WP; Yalowich JC
    Mol Pharmacol; 2001 Mar; 59(3):453-61. PubMed ID: 11179439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines.
    Chen M; Beck WT
    Oncol Res; 1995; 7(2):103-11. PubMed ID: 7579726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin.
    Assefa Z; Vantieghem A; Declercq W; Vandenabeele P; Vandenheede JR; Merlevede W; de Witte P; Agostinis P
    J Biol Chem; 1999 Mar; 274(13):8788-96. PubMed ID: 10085120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
    Morgan SE; Beck WT
    Mol Pharmacol; 2001 Feb; 59(2):203-11. PubMed ID: 11160854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.
    Morgan SE; Kim R; Wang PC; Bhat UG; Kusumoto H; Lu T; Beck WT
    Oncogene; 2000 Oct; 19(43):5010-9. PubMed ID: 11042688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of c-Jun NH2-terminal kinases in isolated canine gastric parietal cells.
    Nagahara A; Wang L; Del Valle J; Todisco A
    Am J Physiol; 1998 Oct; 275(4):G740-8. PubMed ID: 9756505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids.
    Testolin L; Carson C; Wang Y; Walker PR; Armato U; Sikorska M
    Exp Cell Res; 1997 Feb; 230(2):220-32. PubMed ID: 9024781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of caspases in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils.
    Zhang JP; Wong CK; Lam CW
    Clin Exp Immunol; 2000 Oct; 122(1):20-7. PubMed ID: 11012613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.
    Kusumoto H; Rodgers QE; Boege F; Raimondi SC; Beck WT
    Cancer Res; 1996 Jun; 56(11):2573-83. PubMed ID: 8653700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis and activation of interleukin 1beta-converting enzyme/Ced-3 protease (caspase-3) and c-Jun NH2-terminal kinase 1 by benzo(a)pyrene.
    Lei W; Yu R; Mandlekar S; Kong AN
    Cancer Res; 1998 May; 58(10):2102-6. PubMed ID: 9605752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway.
    Bae MA; Pie JE; Song BJ
    Mol Pharmacol; 2001 Oct; 60(4):847-56. PubMed ID: 11562448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells.
    Tseng SH; Wang CH; Lin SM; Chen CK; Huang HY; Chen Y
    J Cancer Res Clin Oncol; 2004 May; 130(5):285-93. PubMed ID: 14997384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
    Mandlekar S; Yu R; Tan TH; Kong AN
    Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.